Bioceres Crop Solutions

BIOX · NASDAQ

$0.2518+$0.0032 (+1.29%)TodayMarket closed · Oct 21, 4:00 AM ET

Prev close $0.2486

BIOX analyst rating

HoldConsensus of 1 analyst over the last 12 months. 0% rate it a buy.

Strong buy0
Buy0
Hold1
Underperform0
Sell0

12-month price target · 3 analysts

Average $2.04 (+710.2% upside)

Low: $2.02
Now: $0.2518
High: $2.10

Upgrades and downgrades

The latest rating actions, newest first

BIOX analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Canaccord Genuity	Jan 2, 2026	Maintains	Hold	$2.25 → $2.00	31%
Canaccord Genuity	Nov 14, 2025	Maintains	Hold	$2.50 → $2.25	31%

The case for and against

Updated Feb 9, 2026

Bull case

Bioceres Crop Solutions Corp demonstrates a positive outlook due to its established crop protection portfolio, which has shown robustness outside of Argentina, indicating strong growth potential amidst domestic challenges. The company’s management is optimistic about international opportunities, particularly for its HB4 wheat revenue anticipated in the United States, Brazil, and Australia, despite acknowledging the time required to ramp up revenues with new partnerships. Additionally, the strong performance of bio-protection products in the U.S. and Latin America, as well as the success of adjuvant sales in Brazil, provide further support for the company’s financial resilience and growth prospects.

Bear case

Bioceres Crop Solutions Corp has experienced significant revenue declines due to weaker demand for its Crop Protection and Crop Nutrition solutions in Argentina, compounded by lower contributions from HB4-related sales following a shift to a licensing-based business model. Specifically, Crop Nutrition revenues decreased by approximately 34% year-over-year, amounting to around $25 million, as pricing pressures and reduced corn acreage have impacted market performance. Additionally, revenues from Seed and Integrated products fell drastically by about 75% year-over-year to approximately $8 million, highlighting the challenges faced during the transition to a seed technology partnership.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.